Novartis Healthcare A/S
Public limited companyCVR 20575786København SActive
Novartis Healthcare A/S is a public limited company, based in København S, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1997. Net profit rose 131% from 2024 to 2025, ending at DKK 30.4m. With 93 employees, the company is about 10 times larger than the industry median. Equity fell to DKK 184.5m in 2025.
Key figures · financial year 2025
RevenueDKK 782.8m−16.5% vs. 2024
Net profitDKK 30.4m+130.8% vs. 2024
EquityDKK 184.5m−27.4% vs. 2024
Employees93latest month from CVR
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit rose 22% (2024 → 2025), to DKK 163.7m.
- Revenue fell 17% (2024 → 2025), to DKK 782.8m.
- Net profit rose 131% (2024 → 2025), to DKK 30.4m.
- Equity fell 27% (2024 → 2025), to DKK 184.5m.
Employees
- 2 fewer employees than a year earlier: 93 (08/2026) against 95 (08/2025).
Management and owners, last 24 months
- New in management: Frances Clare Milnes (board member, 19/12/2024).
- Stepped down: Johan Mikael Olof Kahlström (board member, 19/12/2024).
Registrations, last 24 months
- 01/10/2025: Moved to Kay Fiskers Plads 10, 2, 2300 København S
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | 1,002,386 | 701,904 | 592,697 | 914,827 | 937,871 | 782,800 | −16.5% |
| Gross profit | 196,791 | 170,533 | 193,399 | 160,247 | 134,021 | 163,726 | +22.2% |
| Operating profit (EBIT) | 51,369 | 36,719 | 20,153 | 39,206 | 9,382 | 38,381 | +309.1% |
| Profit before tax | 138,257 | 92,541 | 59,574 | 260,320 | 16,657 | 39,060 | +134.5% |
| Net profit | 127,707 | 84,886 | 56,162 | 251,036 | 13,166 | 30,381 | +130.8% |
| Total assets | 820,852 | 943,865 | 942,616 | 651,310 | 442,225 | 289,981 | −34.4% |
| Equity | 148,873 | 233,759 | 289,921 | 540,957 | 254,123 | 184,502 | −27.4% |
| Liabilities | 671,979 | 705,956 | 649,350 | 106,651 | 137,999 | 102,121 | −26% |
| Average number of employees | 126 | 121 | 128 | 104 | 92 | 91 | −1.1% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresProfit for five years in a row
Net result has been positive in 2021–2025.
How is this calculated?
Net result is positive in the five latest annual reports in a row.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 26/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 27/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 13/06/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 12/05/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 30/06/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 16/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
232 companies in the databaseComparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.
Gross profitDKK 163.7mNo. 15 of 232
Better than 94% of the companies in the industry
EquityDKK 184.5mNo. 16 of 232
Better than 94% of the companies in the industry
Number of employees93No. 23 of 232
Better than 90% of the companies in the industry
Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with 50–199 employees4,467 companies in the comparison | No. 260of 4,412 Better than 94% | No. 366of 4,466 Better than 92% |
| Same industry and 50–199 employees30 companies in the comparison | No. 10of 30 Better than 69% | No. 11of 30 Better than 66% |
| Companies that are between 15 and 29 years old24,910 companies in the comparison | No. 422of 24,791 Better than 98% | No. 833of 24,909 Better than 97% |
| All companies of type A/S18,025 companies in the comparison | No. 977of 17,786 Better than 95% | No. 1,522of 18,024 Better than 92% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Wholesale of pharmaceutical goods and nursing suppliesGross profit
- Novartis Healthcare A/SDKK 163.7m
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
Net profit
- Novartis Healthcare A/SDKK 30.4m
- Ambu A/SDKK 609m
- Stada Nordic ApSDKK 54.6m
Equity
- Novartis Healthcare A/SDKK 184.5m
- Ambu A/SDKK 6bn
- Stada Nordic ApSDKK 346.3m
Employees
- Novartis Healthcare A/S93
- Ambu A/S619
- Stada Nordic ApS51
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership RegisterOwners
- Novartis Pharma AG100%
Novartis Healthcare A/S
Management
4 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Peter Drøidal | CEO | 08/02/2021 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Peter Drøidal | Board member | 15/05/2020 |
| Uffe Mark Hansen | Chair of the board | 31/05/2023 |
| Frances Clare Milnes | Board member | 19/12/2024 |
- Auditor
- KPMG P/S
Former management (36)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Peter-Ulrik Plesner | Board member | 17/12/1997 | 24/10/2002 |
| Jesper Lett | Board member | 17/12/1997 | 29/04/1999 |
| Jacob Rasmus Iversen | Board member | 17/12/1997 | 20/05/1998 |
| Jean-Claude Dubos | Board member | 17/12/1997 | 22/05/2000 |
| Jean-Claude Dubos | Director | 17/12/1997 | 22/05/2000 |
| Montague William Style | Board member | 17/12/1997 | 20/05/1998 |
| Peter Byam Hewes | Chair of the board | 17/12/1997 | 23/05/2001 |
| Roland Sebastian Mirow | Chair of the board | 20/05/1998 | 29/04/1999 |
| Henning Remmer | Board member | 20/06/2000 | 27/03/2002 |
| Henning Remmer | Director | 20/06/2000 | 27/03/2002 |
| Jan Olof Eriksson | Chair of the board | 23/05/2001 | 15/03/2005 |
| Urs Hans Tanner | Board member | 01/10/2001 | 30/05/2004 |
| Alexander David Hardy | Board member | 08/04/2002 | 25/05/2005 |
| Alexander David Hardy | Director | 08/04/2002 | 25/05/2005 |
| Jean-Claude Dubos | Board member | 30/05/2004 | 30/07/2012 |
| Christopher Lewis Kaplan | Chair of the board | 15/03/2005 | 26/11/2007 |
| Hari Sven Venkita Ayer Krishnan | Board member | 25/05/2005 | 13/12/2006 |
| Hari Sven Venkita Ayer Krishnan | Director | 25/05/2005 | 14/12/2006 |
| Jason Smith | Board member | 13/12/2006 | 30/03/2009 |
| Jason Smith | CEO | 14/12/2006 | 14/04/2009 |
| Onno Robert Jurgen Lumiers | Chair of the board | 26/11/2007 | 05/07/2013 |
| Thomas Weigold | Board member | 30/03/2009 | 21/06/2011 |
| Peter Drøidal | CEO | 26/05/2009 | 06/12/2010 |
| Thomas Weigold | CEO | 06/12/2010 | 21/06/2011 |
| Niklas Olof Karlberg | Board member | 21/06/2011 | 10/05/2019 |
| Niklas Olof Karlberg | CEO | 21/06/2011 | 10/05/2019 |
| Karin Maria Botha | Board member | 15/04/2013 | 15/05/2020 |
| Sue Ann Webb | Chair of the board | 05/07/2013 | 30/11/2015 |
| Carsten Gleerup | Board member | 24/04/2014 | 14/05/2020 |
| Knut Ulrich Mager | Chair of the board | 30/11/2015 | 15/05/2020 |
| Judith Louise Love | Board member | 10/05/2019 | 25/03/2022 |
| Judith Louise Love | CEO | 10/05/2019 | 08/02/2021 |
| Carsten Gleerup | Chair of the board | 15/05/2020 | 31/05/2023 |
| Uffe Mark Hansen | Deputy board member | 15/05/2020 | 30/05/2023 |
| Geir Roger Høli | Board member | 25/03/2022 | 02/09/2022 |
| Johan Mikael Olof Kahlström | Board member | 02/09/2022 | 19/12/2024 |
Signing rule: Selskabet tegnes af to bestyrelsesmedlemmer i forening eller af en direktør i forening med et bestyrelsesmedlem
Address and production units
1 active production unitsKay Fiskers Plads 10
2300 København S
| Production unit | Address | Employees | P number |
|---|---|---|---|
| NOVARTIS HEALTHCARE A/S | Kay Fiskers Plads 10, 2, 2300 København S | 93 | 1003095544 |
Purpose
Selskabets formål er at drive handel, industri og finansiering samt anden dermed beslægtet virksomhed, herunder at drive virksomhed gennem datterselskaber
The purpose is quoted from the register in Danish.
Changes year by year
91 registered events22015
02016
02017
02018
42019
62020
32021
52022
42023
32024
22025
12026
20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaddress 1 · accounts 1
- AddressMoved to Kay Fiskers Plads 10, 2, 2300 København S
- AccountsAnnual report for 2024 published
20243 changesmanagement 2 · accounts 1
- ManagementFrances Clare Milnes appointed board member
- ManagementJohan Mikael Olof Kahlström stepped down as board member
- AccountsAnnual report for 2023 published
20234 changesmanagement 3 · accounts 1
- ManagementUffe Mark Hansen appointed chair of the board
- ManagementCarsten Gleerup stepped down as chair of the board
- ManagementUffe Mark Hansen stepped down as deputy board member
- AccountsAnnual report for 2022 published
20225 changesmanagement 4 · accounts 1
- ManagementJohan Mikael Olof Kahlström appointed board member
- ManagementGeir Roger Høli stepped down as board member
- AccountsAnnual report for 2021 published
- ManagementGeir Roger Høli appointed board member
- ManagementJudith Louise Love stepped down as board member
20213 changesaccounts 1 · management 2
- AccountsAnnual report for 2020 published
- ManagementPeter Drøidal appointed ceo
- ManagementJudith Louise Love stepped down as ceo
20206 changesmanagement 6
- ManagementUffe Mark Hansen appointed deputy board member
- ManagementPeter Drøidal appointed board member
- ManagementCarsten Gleerup appointed chair of the board
- ManagementKnut Ulrich Mager stepped down as chair of the board
- ManagementKarin Maria Botha stepped down as board member
- ManagementCarsten Gleerup stepped down as board member
20194 changesmanagement 4
- ManagementJudith Louise Love appointed ceo
- ManagementJudith Louise Love appointed board member
- ManagementNiklas Olof Karlberg stepped down as board member
- ManagementNiklas Olof Karlberg stepped down as ceo
20152 changesmanagement 2
- ManagementKnut Ulrich Mager appointed chair of the board
- ManagementSue Ann Webb stepped down as chair of the board
20141 changemanagement 1
- ManagementCarsten Gleerup appointed board member
20133 changesmanagement 3
- ManagementSue Ann Webb appointed chair of the board
- ManagementOnno Robert Jurgen Lumiers stepped down as chair of the board
- ManagementKarin Maria Botha appointed board member
20122 changesaddress 1 · management 1
- AddressMoved to Edvard Thomsens Vej 14, 3, 2300 København S
- ManagementJean-Claude Dubos stepped down as board member
20114 changesmanagement 4
- ManagementNiklas Olof Karlberg appointed board member
- ManagementNiklas Olof Karlberg appointed ceo
- ManagementThomas Weigold stepped down as ceo
- ManagementThomas Weigold stepped down as board member
20102 changesmanagement 2
- ManagementThomas Weigold appointed ceo
- ManagementPeter Drøidal stepped down as ceo
20095 changescapital 1 · management 4
- CapitalShare capital changed from 12,001,000 DKK to 14,001,000 DKK
- ManagementPeter Drøidal appointed ceo
- ManagementJason Smith stepped down as ceo
- ManagementThomas Weigold appointed board member
- ManagementJason Smith stepped down as board member
20072 changesmanagement 2
- ManagementOnno Robert Jurgen Lumiers appointed chair of the board
- ManagementChristopher Lewis Kaplan stepped down as chair of the board
20065 changescapital 1 · management 4
- CapitalShare capital changed from 10,001,000 DKK to 12,001,000 DKK
- ManagementJason Smith appointed ceo
- ManagementHari Sven Venkita Ayer Krishnan stepped down as director
- ManagementJason Smith appointed board member
- ManagementHari Sven Venkita Ayer Krishnan stepped down as board member
20056 changesmanagement 6
- ManagementHari Sven Venkita Ayer Krishnan appointed director
- ManagementHari Sven Venkita Ayer Krishnan appointed board member
- ManagementAlexander David Hardy stepped down as director
- ManagementAlexander David Hardy stepped down as board member
- ManagementChristopher Lewis Kaplan appointed chair of the board
- ManagementJan Olof Eriksson stepped down as chair of the board
20043 changescapital 1 · management 2
- CapitalShare capital changed from 8,001,000 DKK to 10,001,000 DKK
- ManagementJean-Claude Dubos appointed board member
- ManagementUrs Hans Tanner stepped down as board member
20028 changesmanagement 5 · ownership 1 · capital 1 · merger 1
- ManagementPeter-Ulrik Plesner stepped down as board member
- OwnershipNovartis Pharma AG registered as owner (100%)
- CapitalShare capital changed from 8,000,000 DKK to 8,001,000 DKK
- MergerMerger registered in CVR
- ManagementAlexander David Hardy appointed director
- ManagementAlexander David Hardy appointed board member
- ManagementHenning Remmer stepped down as board member
- ManagementHenning Remmer stepped down as director
20013 changesmanagement 3
- ManagementUrs Hans Tanner appointed board member
- ManagementJan Olof Eriksson appointed chair of the board
- ManagementPeter Byam Hewes stepped down as chair of the board
20004 changesmanagement 4
- ManagementHenning Remmer appointed board member
- ManagementHenning Remmer appointed director
- ManagementJean-Claude Dubos stepped down as director
- ManagementJean-Claude Dubos stepped down as board member
19992 changesmanagement 2
- ManagementRoland Sebastian Mirow stepped down as chair of the board
- ManagementJesper Lett stepped down as board member
19983 changesmanagement 3
- ManagementRoland Sebastian Mirow appointed chair of the board
- ManagementMontague William Style stepped down as board member
- ManagementJacob Rasmus Iversen stepped down as board member
19978 changesfounded 1 · management 7
- FoundedRegistered as NOVARTIS HEALTHCARE A/S
- ManagementJesper Lett appointed board member
- ManagementPeter Byam Hewes appointed chair of the board
- ManagementMontague William Style appointed board member
- ManagementJean-Claude Dubos appointed director
- ManagementJean-Claude Dubos appointed board member
- ManagementJacob Rasmus Iversen appointed board member
- ManagementPeter-Ulrik Plesner appointed board member
Related companies
Same industry in København
- Nomeco A/S939 employees
- Abacus Medicine A/S388 employees
- Novo Nordisk Denmark A/S300 employees
- Msd Danmark ApS132 employees
- Astrazeneca A/S122 employees
- Sandoz A/S118 employees
Same people in management
- Hartmann Packaging A/Svia Peter-Ulrik Plesner
- Sandoz A/Svia Alexander David Hardy
- Sonoco Skjern ApSvia Peter-Ulrik Plesner
- Alcon Nordic A/Svia Carsten Gleerup
- Triumph International Textil A/Svia Peter-Ulrik Plesner
- Eva Trio A/Svia Peter-Ulrik Plesner
Largest in the industry
- Ambu A/SDKK 3.6bn
- Stada Nordic ApSDKK 687m
- Nomeco A/SDKK 683m
- Orifarm Supply A/SDKK 538.5m
- Novo Nordisk Denmark A/SDKK 497.5m
- Sandoz A/SDKK 260.2m
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026.